Karnon J - Search Results

1

Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6.

Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD; ISPOR-SMDM Modeling Good Research Practices Task Force. Briggs AH, et al. Among authors: karnon j. Value Health. 2012 Sep-Oct;15(6):835-42. doi: 10.1016/j.jval.2012.04.014. Value Health. 2012. PMID: 22999133 Free article.

2

The value of value of information: best informing research design and prioritization using current methods.

Eckermann S, Karnon J, Willan AR. Eckermann S, et al. Among authors: karnon j. Pharmacoeconomics. 2010;28(9):699-709. doi: 10.2165/11537370-000000000-00000. Pharmacoeconomics. 2010. PMID: 20629473

3

Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.

Karnon J, Stahl J, Brennan A, Caro JJ, Mar J, Möller J; ISPOR-SMDM Modeling Good Research Practices Task Force. Karnon J, et al. Value Health. 2012 Sep-Oct;15(6):821-7. doi: 10.1016/j.jval.2012.04.013. Value Health. 2012. PMID: 22999131 Free article.

4

Should the Lambda (λ) Remain Silent?

Haji Ali Afzali H, Karnon J, Sculpher M. Haji Ali Afzali H, et al. Among authors: karnon j. Pharmacoeconomics. 2016 Apr;34(4):323-9. doi: 10.1007/s40273-015-0359-7. Pharmacoeconomics. 2016. PMID: 26660350 No abstract available.

5

Exploring structural uncertainty in model-based economic evaluations.

Afzali HH, Karnon J. Afzali HH, et al. Among authors: karnon j. Pharmacoeconomics. 2015 May;33(5):435-43. doi: 10.1007/s40273-015-0256-0. Pharmacoeconomics. 2015. PMID: 25601288 Review.

6

Addressing the challenge for well informed and consistent reimbursement decisions: the case for reference models.

Haji Ali Afzali H, Karnon J. Haji Ali Afzali H, et al. Among authors: karnon j. Pharmacoeconomics. 2011 Oct;29(10):823-5. doi: 10.2165/11593000-000000000-00000. Pharmacoeconomics. 2011. PMID: 21770483 No abstract available.

7

Calibrating models in economic evaluation: a seven-step approach.

Vanni T, Karnon J, Madan J, White RG, Edmunds WJ, Foss AM, Legood R. Vanni T, et al. Among authors: karnon j. Pharmacoeconomics. 2011 Jan;29(1):35-49. doi: 10.2165/11584600-000000000-00000. Pharmacoeconomics. 2011. PMID: 21142277

8

Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria.

Karnon J, Vanni T. Karnon J, et al. Pharmacoeconomics. 2011 Jan;29(1):51-62. doi: 10.2165/11584610-000000000-00000. Pharmacoeconomics. 2011. PMID: 21142278

9

Determining Value in Health Technology Assessment: Stay the Course or Tack Away?

Caro JJ, Brazier JE, Karnon J, Kolominsky-Rabas P, McGuire AJ, Nord E, Schlander M. Caro JJ, et al. Among authors: karnon j. Pharmacoeconomics. 2019 Mar;37(3):293-299. doi: 10.1007/s40273-018-0742-2. Pharmacoeconomics. 2019. PMID: 30414074 Free PMC article.

10

Model Structuring for Economic Evaluations of New Health Technologies.

Haji Ali Afzali H, Bojke L, Karnon J. Haji Ali Afzali H, et al. Among authors: karnon j. Pharmacoeconomics. 2018 Nov;36(11):1309-1319. doi: 10.1007/s40273-018-0693-7. Pharmacoeconomics. 2018. PMID: 30030816 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results